<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02789436</url>
  </required_header>
  <id_info>
    <org_study_id>05-PA-26-10/15</org_study_id>
    <nct_id>NCT02789436</nct_id>
  </id_info>
  <brief_title>Effect of Probiotic Lozenges on Halitosis in Patients With Chronic Periodontitis</brief_title>
  <official_title>Effect of Probiotic Lactobacillus Reuteri-containing Lozenges (Prodentis) on Halitosis in Patients With Chronic Periodontitis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Zagreb</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>BioGaia AB</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Zagreb</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine whether Lactobacillus reuteri-containing lozenges
      (Prodentis) are effective in treatment of halitosis in patients with chronic periodontitis.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Bad breath (oral malodor, lat. halitosis) is amongst most common patients' complaints in the
      dental office. Ironically, available literature and research done on this topic thus far are
      relatively scarce. Oral malodor is most commonly caused by oral bacteria (87%), yet it can
      also be sourced from ear, nose and throat region and in a small percentage from distant parts
      of the body or is of unknown origin. Periodontal pathogens and other Gram(-) anaerobic
      microorganisms such as Porphyromonas gingivalis, Treponema denticola, Prevotella intermedia,
      Fusobacterium nucleatum, Enterobacter cloacae, Prevotella loescheii and Porphyromonas
      endodontalis are regarded as producers of malodorous gases. Namely, these bacterial species
      and periodontal pathogens particularly produce so called volatile sulfur compounds (VSC)
      which give mouth air its malodorness. Methylmercaptan, hydrogen sulfide and dimethyl sulfide
      are waste products of bacterial metabolism, specifically degradation of sulfur-, methionine-
      and cysteine-containing aminoacids. Offensive smells also stem from other compounds which do
      not contain sulfur, diamines and polyamines such as cadaverine, putrescine and skatole.

      Probiotics are defined as living microorganisms which are considered to have beneficial
      health effect on their host when consumed in adequate amount. Regarding their advantageous
      role in periodontal disease, inhibition of specific periodontal pathogens and alteration of
      host immune response through multifactorial causes are thought to be their main working
      mechanisms. Reuterin and reutericyclin are two bacteriocins produced by Lactobacillus reuteri
      that inhibit growth of pathogenic bacteria, while bacterium also exhibits strong capacity of
      host tissue adherence and subsequent competition with pathogens.

      Based on this data, research on efficacy of probiotic lozenges on halitosis in patients with
      chronic periodontitis.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Not yet recruiting</last_known_status>
  <start_date>June 2016</start_date>
  <primary_completion_date type="Anticipated">September 2016</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in VSC concentration in mouth air</measure>
    <time_frame>28 days</time_frame>
    <description>Assessed with halimeter</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Changes in halitosis associated quality of life</measure>
    <time_frame>28 days</time_frame>
    <description>Assessed with Halitosis Associated Life-quality Test (Kizhnev et al., 2011)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from Baseline in Plaque Accumulation (PCR)</measure>
    <time_frame>28 days</time_frame>
    <description>Assessed with PCR index (Plaque Control Record - O'Leary et al., 1972)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from Baseline in Bleeding on Probing (BOP)</measure>
    <time_frame>28 days</time_frame>
    <description>Assessed with BOP index (Bleeding on Probing, Ainamo and Bay, 1975)</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Halitosis</condition>
  <arm_group>
    <arm_group_label>L. reuteri Prodentis® lozenges</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>15 subjects
Probiotic lozenges used in the trial is a non-commercial product provided by BioGaia AB, Lund, Sweden. The Probiotic lozenges consist of a minimum of 200 million live L. reuteri (L. reuteri DSM 17938 and L. reuteri ATCC PTA 5289 (L. reuteri Prodentis®). Probiotic lozenges are used twice daily for 28 days.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo lozenges</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>15 subjects
Placebo lozenges used in the trial is non-commercial product provided by BioGaia AB, Lund, Sweden.Placebo lozenges are taken twice daily for 28 days.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>L. reuteri Prodentis® lozenges</intervention_name>
    <description>Twice daily, for 28 days</description>
    <arm_group_label>L. reuteri Prodentis® lozenges</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Placebo lozenges</intervention_name>
    <description>Twice daily, for 28 days</description>
    <arm_group_label>Placebo lozenges</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Adult patients, above age of 30

          -  Non-smokers or ex-smokers (not smoking in the past year)

          -  Moderate to advanced untreated chronic periodontitis

          -  Good compliance and following of oral hygiene instructions

          -  Halitosis in active phase and patient's subjective complaint

          -  Informed consent by the patient

        Exclusion Criteria

          -  Aggressive periodontitis

          -  Antibiotics administered up to 3 months prior to this study

          -  Pregnancy and breastfeeding

          -  Immunosuppressive therapy

          -  Oral neoplasms (including radiation or chemotherapy)

          -  Diabetes mellitus

          -  Acute oral inflammation or infection

          -  Poor, unsatisfactory oral hygiene and lack of compliance

          -  Use of dietary supplements containing probiotics within 2 weeks prior to study start
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>30 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Darije Plančak, Professor</last_name>
    <role>Study Director</role>
    <affiliation>University of Zagreb, School of Dental Medicine</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Larisa Musić, DMD</last_name>
    <email>lmusic@sfzg.hr</email>
  </overall_contact>
  <location>
    <facility>
      <name>University of Zagreb, School of Dental Medicine Zagreb</name>
      <address>
        <city>Zagreb</city>
        <zip>10000</zip>
        <country>Croatia</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Larisa Musić, DMD</last_name>
      <email>lmusic@sfzg.hr</email>
    </contact>
  </location>
  <location_countries>
    <country>Croatia</country>
  </location_countries>
  <reference>
    <citation>Loesche WJ, Kazor C. Microbiology and treatment of halitosis. Periodontol 2000. 2002;28:256-79. Review.</citation>
    <PMID>12013345</PMID>
  </reference>
  <reference>
    <citation>Delanghe G, Ghyselen J, van Steenberghe D, Feenstra L. Multidisciplinary breath-odour clinic. Lancet. 1997 Jul 19;350(9072):187.</citation>
    <PMID>9250193</PMID>
  </reference>
  <reference>
    <citation>Persson S, Claesson R, Carlsson J. The capacity of subgingival microbiotas to produce volatile sulfur compounds in human serum. Oral Microbiol Immunol. 1989 Sep;4(3):169-72.</citation>
    <PMID>2639302</PMID>
  </reference>
  <reference>
    <citation>Persson S, Edlund MB, Claesson R, Carlsson J. The formation of hydrogen sulfide and methyl mercaptan by oral bacteria. Oral Microbiol Immunol. 1990 Aug;5(4):195-201.</citation>
    <PMID>2082242</PMID>
  </reference>
  <reference>
    <citation>Goldberg S, Kozlovsky A, Gordon D, Gelernter I, Sintov A, Rosenberg M. Cadaverine as a putative component of oral malodor. J Dent Res. 1994 Jun;73(6):1168-72.</citation>
    <PMID>8046106</PMID>
  </reference>
  <reference>
    <citation>Walker WA. Mechanisms of action of probiotics. Clin Infect Dis. 2008 Feb 1;46 Suppl 2:S87-91; discussion S144-51. doi: 10.1086/523335. Review.</citation>
    <PMID>18181730</PMID>
  </reference>
  <reference>
    <citation>Haukioja A. Probiotics and oral health. Eur J Dent. 2010 Jul;4(3):348-55.</citation>
    <PMID>20613927</PMID>
  </reference>
  <verification_date>May 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 4, 2016</study_first_submitted>
  <study_first_submitted_qc>May 29, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 3, 2016</study_first_posted>
  <last_update_submitted>May 29, 2016</last_update_submitted>
  <last_update_submitted_qc>May 29, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 3, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Zagreb</investigator_affiliation>
    <investigator_full_name>Larisa Musić</investigator_full_name>
    <investigator_title>Doctor of Dental Medicine</investigator_title>
  </responsible_party>
  <keyword>halitosis</keyword>
  <keyword>chronic periodontitis</keyword>
  <keyword>probiotic</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Periodontitis</mesh_term>
    <mesh_term>Chronic Periodontitis</mesh_term>
    <mesh_term>Halitosis</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

